Free Trial

InMed Pharmaceuticals (INM) SEC Filings & 10K Form

InMed Pharmaceuticals logo
$3.12 -0.27 (-7.96%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$3.14 +0.02 (+0.64%)
As of 02/21/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/14/2025
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:38 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
4:30 PM
InMed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/03/2025
10:20 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
7:49 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
9:18 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
9:54 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
10:46 AM
InMed Pharmaceuticals (Filer)
Form 424B3
01/01/2025
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
12/30/2024
11:16 AM
InMed Pharmaceuticals (Filer)
Form S-1/A
12/23/2024
4:16 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
8:25 AM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:26 AM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:28 AM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:17 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:18 AM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:20 AM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:21 AM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:22 AM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:24 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:18 AM
InMed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/19/2024
10:55 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:05 AM
InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
Form SCHEDULE 13G
11/12/2024
12:44 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G
11/05/2024
8:08 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:50 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
3:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:25 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2024
2:57 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:28 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:30 AM
InMed Pharmaceuticals (Filer)
Form 424B3
09/30/2024
12:37 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:10 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
1:04 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
2:08 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:32 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
11:48 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:26 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
12:30 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
1:39 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Real Hillbilly Elegy (Ad)

The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond… It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest. It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground.

A bold new plan, hidden in Executive Order 14154…
04/05/2024
10:26 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
12:44 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
2:20 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
2:27 PM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/22/2024
12:38 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners